FDA steps up public communication on drug safety

02/26/2008 | Washington Post, The

The FDA is giving the public more information on drug safety, as evidenced by the 14 advisories it has issued since November. Paul Seligman, director of the FDA's Office of Drug Safety, said the agency is making good on HHS Secretary Mike Leavitt's pledge to promptly inform the public of the side effects of approved drugs. Rep. John Dingell, D-Mich., an FDA critic, has deemed the development "a quantum improvement."

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA